🇺🇸 FDA
Pipeline program

TEMOZOLOMIDE, TEMOZOLOMIDE, CAPECITABINE

Phase 2 small_molecule active

Quick answer

TEMOZOLOMIDE, TEMOZOLOMIDE, CAPECITABINE for locally advanced rectal cancer (LARC) is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).

Program details

Company
Fondazione Telethon ETS
Indication
locally advanced rectal cancer (LARC)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials